Vivien Bachmann

Vivien Bachmann

Auto-generated profile, based on publicly available information

Vivien Bachmann

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, 07743 Jena, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
Paul Mike JordanPaul Mike Jordan
Paul Mike Jordan
LPLukas K. Peltner
Lukas K. Peltner
VBVivien Bachmann
Vivien Bachmann
PDPhilipp Dahlke
Philipp Dahlke
SPSimona Pace
Simona Pace
OWOliver Werz
Oliver Werz
Inflammation resolution is governed by specialized pro-resolving mediators (SPM), mainly formed from omega-3 polyunsaturated fatty acids (n-3 PUFA) by lipoxygenases (LOX), which terminate inflammatory processes and facilitate healing and tissue repair. Promoting endogenous SPM formation, besides therapeutic SPM application, is an innovative concept for intervention in inflammatory diseases, achievable by allosteric 15-LOX activation. Here, targeted screening of the 29 most frequently applied anti-inflammatory natural products using lipid mediator metabololipidomics uncovered the acylphloroglucinols hyperforin, arzanol, garcinol, Myrtucommulone A and the lignan magnolol as potent 15-LOX activators to elicit robust SPM production in resting human M2-like macrophages. Simultaneous n-3 PUFA supplementation synergistically enhanced SPM formation in these M2-like macrophages, most strikingly with magnolol. Comprehensive targeted metabololipidomics in activated human polymorphonuclear leukocytes, monocytes, and M1-/M2-like macrophages revealed shifts from pro-inflammatory cyclooxygenase (COX) and 5-LOX products to pro-resolving 15-LOX products by magnolol and acylphloroglucinols. Finally, using zymosan-induced peritonitis in mice, application of a magnolol/n-3 PUFA combination confirmed synergistic SPM elevation in vivo. Together, we established an approach based on synergism of natural allosteric 15-LOX activators and supplemented n-3 PUFA to accomplish SPM-based resolution pharmacology.

8 June 2026 in Journal of Lipid Research
Verified
Journal Article
Open access
RHRobert Klaus Hofstetter
Robert Klaus Hofstetter
MWMarkus Werner
Markus Werner
PSPatrick Schädel
Patrick Schädel
MWMareike Wichmann-Costaganna
Mareike Wichmann-Costaganna
KFKatrin Fischer
Katrin Fischer
OWOliver Werz
Oliver Werz
Specialized pro-resolving mediators (SPM) are di- or trihydroxylated polyunsaturated fatty acids with potent inflammation-resolving features. SPM typically occur at lower concentrations than classical pro-inflammatory eicosanoids, making their detection highly challenging. Thus, reporting of biological SPM levels has been discrepant and not always transparent, sparking uncertainty concerning the formation capacity for di- and especially for trihydroxylated SPM in vitro and in vivo. Here, we create common ground by providing a systematic and comprehensive assessment of SPM formation across a broad range of commonly employed in vitro, ex vivo, and in vivo matrices. For this purpose, a quantitative UHPLC-MS/MS method targeting 72 oxylipins (including 19 SPM) was validated in accordance with recommendations by the International Lipidomics Society. By including sample preparation (solid phase extraction) in all validation processes, a conservative lower limit of quantification (10-100 pg/mL matrix) was found to meet clearly defined criteria for signal/noise, accuracy, precision, selectivity, specificity, matrix effects, recovery, and carry-over for 19 SPM. Our results offer analytically defensible reference data to demonstrate (i) the absence of relevant SPM levels in stimulated whole blood and unstimulated cell models; (ii) only trace SPM formation in stimulated peripheral blood mononuclear cells, M1-macrophages, neutrophils, and platelet incubations; but (iii) significant SPM formation in stimulated M2a-macrophages and neutrophil/platelet co-incubations. In healthy C57BL/6JRj mice, SPM formation was low yet organ-specific, with relevant amounts of dihydroxylated SPM detected in spleen. Taken together, we demonstrate SPM formation to be robust, matrix- and stimulus-dependent, but confined to specific di- and trihydroxylated SPM.